Luiza Cristina Dumitrof

Dr. Luiza Cristina Dumitrof


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Medicina
Verified
Journal Article
Open access
PDF file
LDLuiza Cristina Dumitrof
Luiza Cristina Dumitrof
INIgor Nedelciuc
Igor Nedelciuc
MRMihai Roca
Mihai Roca
Radu CRIȘAN-DABIJARadu CRIȘAN-DABIJA
Radu CRIȘAN-DABIJA
TMTraian Mihăescu
Traian Mihăescu
GTGrigore Tinica
Grigore Tinica
Background and Objectives: Since the first transcatheter aortic valve implantation (TAVI) procedure was performed in 2002, advances in technology and refinement of the method have led to its widespread use in patients with severe aortic stenosis (AS) and high surgical risk. We aim to identify the impact of TAVI on the clinical and functional status of patients with severe AS at the one-month follow-up and to identify potential predictors associated with the evolution of pulmonary hypertension (PH) in this category of patients. Materials and Methods: We conducted a prospective study which included 86 patients diagnosed with severe AS undergoing TAVI treatment. We analyzed demographics, clinical and echocardiographic parameters associated with AS and PH both at enrolment and at the 30-day follow-up. Results: In our study, the decrease of EUROSCORE II score (p < 0.001), improvement of angina (p < 0.001) and fatigue (p < 0.001) as clinical benefits as well as a reduction in NYHA functional class in patients with heart failure (p < 0.001) are prognostic predictors with statistical value. Regression of left ventricular hypertrophy (p = 0.001), increase in the left ventricle ejection fraction (p = 0.007) and improvement of diastolic dysfunction (p < 0.001) are echocardiographic parameters with a prognostic role in patients with severe AS undergoing TAVI. The pulmonary artery acceleration time (PAAT) (p < 0.001), tricuspid annular plane systolic excursion (TAPSE) (p = 0.020), pulmonary arterial systolic pressure (PASP) (p < 0.001) and the TAPSE/PASP ratio (p < 0.001) are statistically significant echocardiographic parameters in our study that assess both PH and its associated prognosis in patients undergoing TAVI. Conclusions: PAAT, TAPSE, PASP and the TAPSE/PASP ratio are independent predictors that allow the assessment of PH and its prognostic implications post-TAVI.

1 December 2022 in Internal Medicine
Verified
Journal Article
Open access
PDF file
LDLuiza Cristina Dumitrof
Luiza Cristina Dumitrof
INIgor Nedelciuc
Igor Nedelciuc
MRMihai Roca
Mihai Roca
DBDaniela Boișteanu
Daniela Boișteanu
RCRadu Crișan-Dabija
Radu Crișan-Dabija
FMFlorin Mitu
Florin Mitu
Aortic stenosis is one of the most common valve diseases in patients over 60 years of age. Lack of prompt surgical correction by conventional valve replacement or interventional transcatheter aortic valve implantation (TAVI) increases the risk of morbidity and mortality, in the context of worsening clinical picture. Since the first interventional transcatheter valve implantation procedure in 2012 and to date, the evolution of technology and refinement of medical techniques has led to the refinement of the treatment method and thus to the improvement of the prognosis of patients with aortic stenosis undergoing TAVI after only one month.

1 December 2022 in Balneo and PRM Research Journal
Verified
Journal Article
Closed access
LDLuiza Cristina Dumitrof
Luiza Cristina Dumitrof
MRMihai Roca
Mihai Roca
TMTraian Mihăescu
Traian Mihăescu
GTGrigore Tinică
Grigore Tinică